Good for Business, Latvia, Markets and Companies, Medicine
International Internet Magazine. Baltic States news & analytics
Tuesday, 09.06.2026, 07:46
Tamro’s profit grew by 19% in its financial year
Nina Kolyako, BC, Riga, 27.08.2012.
Print version
Print versionPharmaceutical wholesaler Tamro achieved LVL 72.1 million in turnover in the company's 2011/2012 financial year, which lasted from February 1, 2011 to January 31, 2012, according to Firmas.lv information. In 2010/2011, the company's turnover amounted to LVL 73.59 million, 2% less than in 2011/2012.
 |
|---|
The company's profit grew 19% – from LVL 2,312,617 in 2010/2011 to LVL 2,754,026 in 2011/2012, writes LETA.Nozare.lv..
According to the company's management report, Tamro managed to improve its results by successfully balancing the company's client portfolio. Tamro maintained stable positions on the Latvian pharmaceutical market, increasing the company's market share by 2% from the previous financial year.
During the next financial year, Tamro plans to increase the company's sales on the local market and continue developing its loyalty concept "Aptieka 1" and IT accounting system.
Tamro was established in 1993. The company's share capital is LVL 1,311,500, and its shares belong to the Finnish company Tamro Oyi.
«The Baltic Course» Is Sold and Stays in Business!
